STAT

‘A number of new stars’: The definitive guide to the Trump administration’s coronavirus response team

As Trump puts it, the #coronavirus pandemic has created “a number of new stars.” Who’s really calling the shots?
The Trump administration's coronavirus response team.

WASHINGTON — Vice President Mike Pence is in charge of the Trump administration’s response to the coronavirus. But so is Deborah Birx, the physician and diplomat who the Trump administration brought on as its response “coordinator.” Then there’s health secretary Alex Azar, the chair of the Trump administration’s Coronavirus Task Force. And of course, Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, to whom they all seem to defer.

Day after day, as President Trump updates the nation on the coronavirus pandemic, it can be difficult to keep track of the phalanx of government officials behind him. They include doctors, lawyers, researchers, cabinet secretaries, and uniformed members of the Public Health Service Commissioned Corps. The group is ever shifting: Ben Carson, the housing secretary and a neurosurgeon by training, made one recent appearance. CDC Director Robert Redfield, however, has been noticeably absent at recent press conferences.

Trump has also been criticized for not appointing a coronavirus “czar,” as President Obama did during the 2014 Ebola outbreak. Instead, his approach has instead been characterized by a sprawling network of cabinet secretaries, federal agencies, and bureaucrats in a variety of roles.

Who’s really calling the shots?

STAT examines the dizzying array of federal officials — 16 in all — who are shepherding the government’s response. As Trump himself put it, the pandemic has “created a number of new stars.’’

1. President Trump: the decider

Of all the

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: Health Care Leaders Plot How To Expand Diversity In Clinical Trials
Experts gathered at the Milken Institute Global Conference this week to discussed potential strategies to expand diversity in clinical trials. Here are some of their big ideas.
STAT1 min read
STAT+: Senate Drug Shortage Bill Would Pay Hospitals Bonuses For Good Contracting Practices
A bipartisan Senate bill takes a new approach to persistent drug shortages: have Medicare pay bonuses to hospitals and physicians for contracting that ensures a steady supply.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.

Related Books & Audiobooks